AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2013
Mar 5, 2013
32853_dirs_2013-03-05_bcbfed0b-e78c-46d2-b40b-c279e2676ee9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-11-28
Reporting Person: Worthington Gajus Vincent (Director, PRESIDENT & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-28 | Common Stock | S | 21300 | $14.0101 | Disposed | 225159 | Indirect |
Footnotes
F1: This amendment is filed to correctly reflect a sale of shares on November 28, 2012 only. The sale of shares on November 29, 2012 reported in the original filing did not occur.
F2: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2012 by the Worthington Family Trust dated March 6, 2007, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.
F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4: Shares held directly by the Worthingon Family Trust dated March 6, 2007.